RGEN
Repligen Corp
$194.57
0.48 (0.25%) Today
— up— down
Market Cap
$10.98B+56.8%
Revenue (TTM)
$782.35M+16.5%
Net Income (TTM)
$41.41M
$41.41MEPS (TTM)
0.73
0.73Shares Out
56.44M
56.44MP/E Ratio
262.72
262.72Forward P/E
75.29
75.29Open
$194.57
$194.57Previous Close
$194.09
$194.09Day Range
$190.98 – $196.65
$190.98 – $196.6552-Week Range
$100.99 – $198.87
$100.99 – $198.87Beta
1.13
1.13Volume
1.14M
1.14MAvg Volume
1.09M
1.09MAnalyst Rating
Buy
BuyExchange
NASDAQ NMS - GLOBAL MARKET
NASDAQ NMS - GLOBAL MARKETAbout RGEN
Repligen Corporation is an American life sciences company that develops and manufactures products used in biological drug manufacturing. The company is headquartered in Waltham, Massachusetts, and is listed on the Nasdaq under the symbol RGEN.